This time of year is also typically when we see higher infection rates of both COVID-19 and Respiratory Syncytial Virus, or RSV. If you come down with a cough or a fever, you might be wondering ...

The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, according to early data. The benefits are likely to increase as more ...

On average over four seasons, the study found that RSV caused 84.7 hospitalizations per 100,000 among people older than 60 years, and varied significantly depending on age and certain risk factors.

The inventors have created a reverse genetics system for RSV strain B1 of antigenic subgroup B encoding a replication-competent recombinant RSV that contains a codon-optimized G ORF and expresses ...